215 FIRST STREET, CAMBRIDGE, MA
Market cap: $1.9B (2/09/2026)
Price: $18.33
Reports Preliminary* Fourth Quarter and Full-Year 2025 Net Product Revenues
Sarepta Therapeutics Enters $291.4M Exchange Agreement for Convertible Notes
Announces Refinancing of Approximately $291 Million of 1.25% Convertible Senior Notes due 2027
Equity Awards Granted to CEO Douglas S. Ingram - $12 Million Total Value
Earnings Release
News, Securities Holder Rights or Indentures
Unregistered Sales of Equity Securities
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Q3
Q2
Q1
FY 2023
Registration Statement for Securities to be Offered to Employees
S-3ASR
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
S-8 POS